PL174647B1 - Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy - Google Patents

Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy

Info

Publication number
PL174647B1
PL174647B1 PL93321792A PL32179293A PL174647B1 PL 174647 B1 PL174647 B1 PL 174647B1 PL 93321792 A PL93321792 A PL 93321792A PL 32179293 A PL32179293 A PL 32179293A PL 174647 B1 PL174647 B1 PL 174647B1
Authority
PL
Poland
Prior art keywords
methyl
ethyl
dihydro
chlorophenyl
amlodipine
Prior art date
Application number
PL93321792A
Other languages
English (en)
Polish (pl)
Inventor
Borut Furlan
Anton Copar
Alenka Jeriha
Original Assignee
Lek Tovarna Farmacevtskih
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Tovarna Farmacevtskih filed Critical Lek Tovarna Farmacevtskih
Publication of PL174647B1 publication Critical patent/PL174647B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
PL93321792A 1992-11-26 1993-11-17 Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy PL174647B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI9200344A SI9200344B (sl) 1992-11-26 1992-11-26 Postopek za pripravo amlodipin benzensulfonata

Publications (1)

Publication Number Publication Date
PL174647B1 true PL174647B1 (pl) 1998-08-31

Family

ID=20431051

Family Applications (2)

Application Number Title Priority Date Filing Date
PL93301080A PL173645B1 (pl) 1992-11-26 1993-11-17 Sposób wytwarzania monobenzenosulfonianu (+) 2-[(2-aminoetoksy)metylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego
PL93321792A PL174647B1 (pl) 1992-11-26 1993-11-17 Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL93301080A PL173645B1 (pl) 1992-11-26 1993-11-17 Sposób wytwarzania monobenzenosulfonianu (+) 2-[(2-aminoetoksy)metylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego

Country Status (9)

Country Link
EP (1) EP0599220B1 (sl)
CZ (1) CZ283041B6 (sl)
DE (1) DE69304020T2 (sl)
FI (1) FI103042B (sl)
HR (1) HRP931429B1 (sl)
PL (2) PL173645B1 (sl)
RU (1) RU2105759C1 (sl)
SI (1) SI9200344B (sl)
SK (1) SK279353B6 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
UA72768C2 (en) * 1999-07-05 2005-04-15 Richter Gedeon Vegyeszet A method for obtaining amilodipine benzenesulphonate
ATE454890T1 (de) * 2001-07-06 2010-01-15 Lek Pharmaceuticals Verfahren zur herstellung hochreines amlodipinbenzolsulfonat
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
SI21233A (sl) * 2002-05-31 2003-12-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
EP1407773A1 (en) * 2002-10-08 2004-04-14 Council of Scientific and Industrial Research A process for the preparation of s (-) amlodipine salts
WO2004058711A1 (en) * 2002-12-30 2004-07-15 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Isolation of dihydropyridine derivative and preparation salts thereof
JP4539862B2 (ja) 2003-03-28 2010-09-08 日産化学工業株式会社 Ｔ型カルシウムチャネル阻害剤
WO2007131759A1 (en) * 2006-05-15 2007-11-22 Lek Pharmaceuticals D.D. A process for the preparation of amlodipine benzenesulfonate
RS53688B9 (sr) 2008-07-08 2020-01-31 Incyte Holdings Corp 1,2,5-oksadiazoli kao inhibitori indoleamin 2,3-dioksigenaze
SG171722A1 (en) 2008-12-22 2011-07-28 Pola Chem Ind Inc Melanin production inhibitor
CN102516159B (zh) * 2011-12-15 2013-10-09 扬子江药业集团江苏海慈生物药业有限公司 一种苯磺酸左旋氨氯地平的生产方法
EP2911669B1 (en) 2012-10-26 2024-04-10 The University of Chicago Synergistic combination of immunologic inhibitors for the treatment of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
EP0352863A3 (en) * 1988-07-29 1990-08-22 ZAMBON GROUP S.p.A. 1,4-dihydropyridine dicarboxylic acid derivatives

Also Published As

Publication number Publication date
EP0599220B1 (en) 1996-08-14
FI103042B1 (fi) 1999-04-15
FI934882A0 (fi) 1993-11-04
DE69304020D1 (de) 1996-09-19
FI103042B (fi) 1999-04-15
EP0599220A1 (en) 1994-06-01
CZ283041B6 (cs) 1997-12-17
FI934882A (fi) 1994-05-27
PL173645B1 (pl) 1998-04-30
CZ216593A3 (en) 1994-06-15
PL301080A1 (en) 1994-05-30
SI9200344A (en) 1994-06-30
SK112593A3 (en) 1994-11-09
SK279353B6 (sk) 1998-10-07
RU2105759C1 (ru) 1998-02-27
SI9200344B (sl) 1998-06-30
DE69304020T2 (de) 1997-03-06
HRP931429A2 (en) 1995-12-31
HRP931429B1 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
US5389654A (en) 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
PL174647B1 (pl) Sposób wytwarzania (+) 2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylanu-3,5 3-etylowo-5-metylowego i (+)2-[2-(N-trytyloamino) etoksymetylo]-4-(2-chlorofenylo)-1,4-dihydro-6-metylopirydynodwukarboksylan-3,5 3-etylowo-5-metylowy
WO1993006082A1 (en) Process for the preparation of 4-substituted-1,4-dihydropyridines
UA57722C2 (uk) Спосіб одержання солі 3-етил-5-метил-2-(2-аміноетоксиметил)-4-(2-хлорфеніл)-6-метил-1,4-дигідро-3,5-піридиндикарбоксилату і бензолсульфокислоти (безилату амлодипіну)
KR100576166B1 (ko) 아믈로디핀 합성을 위한 중간체, 이의 제조 방법 및 이의용도
CA1330994C (en) Flavone derivatives
CA2425561C (en) Process to prepare 1,4-dihydropyridine intermediates and derivatives thereof
WO2004058711A1 (en) Isolation of dihydropyridine derivative and preparation salts thereof
US5310917A (en) Process for the preparation of 4-substituted-1,4-dihydropydrines
EP0371492B1 (en) Process for the preparation of 1,4-dihydropyridine derivatives
NO842092L (no) Fremgangsmaate for fremstilling av 2,6-disubstituerte-1,4-dihydropyridin-derivater
KR930001404B1 (ko) 디아릴 화합물의 제조방법
US20080242867A1 (en) Acetone solvate of phthaloyl amlodipine
EP0190364A1 (en) Novel 1,4-dihidropyridine-3,5-dicarboxylate derivatives
JP2631644B2 (ja) 複素環式化合物の製造
KR100374405B1 (ko) 암로디핀 베실레이트의 제조방법
CA2463510A1 (en) Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts
CA1261338A (en) Esters of 1,4-dihydro-2,6-dimethyl-3-(alkoxycarbonyl or alkoxyalkoxycarbonyl)-4-(substituted phenyl)- pyridine-5-carboxylic acid
KR100354806B1 (ko) 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
CA2164276C (en) New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
WO2007131759A1 (en) A process for the preparation of amlodipine benzenesulfonate
JPH0575743B2 (sl)
MXPA01004128A (en) Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20121117